Alterity Therapeutics (ATHE) Accumulated Depreciation & Amortization (2023 - 2024)
Alterity Therapeutics' quarterly Accumulated Depreciation & Amortization came in at -$20868.7 in Q2 2024, up 48.69% year-on-year from -$14035.2 in Q3 2023, and up 48.69% quarter-over-quarter from -$40670.9 in Q2 2023.
Alterity Therapeutics has reported Accumulated Depreciation & Amortization for 2 years, with the latest figure at -$20868.7 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -20,868.73 |
| Jun 30, 2024 | -20,868.73 |
| Jun 30, 2023 | -40,670.87 |
| Jun 30, 2023 | -40,670.87 |